Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 19352 | ZM223 | 2031177-48-5 | >98% |  |
| ZM223 is a novel non-sulfamide NEDD8 activating enzyme inhibitor that inhibits HCT116 | ||||
| 189271 | Zamicastat | 1080028-80-3 | >98% |  |
| Zamicastat is a potent and selective dopamine β-mono-oxygenase inhibitor. | ||||
| 185186 | Zardaverine | 101975-10-4 | >98% |  |
| Zardaverine is a Phosphodiesterase 3/4 inhibitor. | ||||
| 18577 | Zanubrutinib | 1691249-45-2 | >98% |  |
| Zanubrutinib, aslo known as BGB-3111, is a potent and highly selective small molecule | ||||
| 17022714 | ZM241385 | 139180-30-6 | 98% |  |
| ZM241385 is an adenosine A2A-receptor antagonist. ZM241385 enhances neuronal survival | ||||
| 17021304 | ZINC00881524 (ROCK inhibitor) | 557782-81-7 | 98% | |
| ZINC00881524 is a ROCK inhibitor. | ||||
| 16122852 | ZLN005 | 49671-76-3 | 98% |  |
| ZLN005 is a PGC-1 Transcriptional Regulator, which shoed some beneficialfEffects on d | ||||
| 16122851 | ZL006 | 1181226-02-7 | 98% |  |
| ZL006 is a PSD95-nNOS protein-protein interaction inhibitor. ZL006 (EC50: 12.88 M) di | ||||
| 16122850 | ZK-756326 dihydrochloride | 1780259-94-0 | 98% | |
| ZK-756326 is a potent, selective and non-peptide CCR8 chemokine receptor agonist. ZK | ||||
| 16122771 | Z-IETD-FMK | 210344-98-2 | 98% |  |
| Z-IETD-FMK is a specific Caspase-8 inhibitor.Z-IETD-FMK, which inhibits the cleavage | ||||
| 16122725 | ZK756326 | 874911-96-3 | 98% |  |
| ZK756326 is a full agonist of CCR8Chemokine receptor 8 with an IC50 of 1.8 M, dose-re | ||||
| 611814 | ZLN024 hydrochloride | 1883548-91-1 | 98% |  |
| ZLN024 Hcl is a novel AMPK allosteric activator; activated 111 and 211 by around 2C2. | ||||
| 161009018 | Zotarolimus | 221877-54-9 | 98% by HPLC |  |
| It is a semi-synthetic derivative of rapamycin. It was designed for use in stents wit | ||||
| 160926006 | ZSTK474 | 475110-96-4 | 98% by HPLC |  |
| Combination treatment using X-rays then ZSTK474 given orally for 8 days, starting 2 | ||||
| 16071403 | Z-Vad-fmk, non-methylated | 161401-82-7 | 98% by HPLC | |
| Z-Vad-fmk, non-methylated | ||||
| 16062112 | Z-DEVD-FMK | 210344-95-9 | 98% by HPLC |  |
| Z-DEVD-FMK(Caspase-3 Inhibitor) is a specific, irreversible Caspase-3 inhibitor, and | ||||
| 16062111 | Z-FA-FMK | 105637-38-5 | 98% by HPLC |  |
| Z-FA-FMK | ||||
| 16062110 | Z-VAD(OH)-FMK | 634911-81-2 | 98% by HPLC | -FMK-cas-634911-81-2.png) |
| Z-VAD(OH)-FMK | ||||
| 011908 | Zibotentan | 186497-07-4 | 98% |  |
| Zibotentan is an orally available selective antagonist of the endothelin-A (ET-A) rec | ||||
| 122923 | ZM 306416 | 690206-97-4 | 98% |  |
| ZM-306416 is a VEGFR inhibitor that inhibits Flk-1 (KDR) (IC50=100 nM) and Flt (IC50 | ||||
| 122214 | ZM 323881 hydrochloride | 324077-30-7 | 98% |  |
|  ZM323881 is a potent and selective inhibitor of VEGF-R2 tyrosine kinase in vitr | ||||
| 121415 | Zucapsaicin | 25775-90-0 | 98% |  |
| Comig soon! | ||||
| 111008 | ZM323881 hydrochloride | 193000-39-4 | 98% |  |
| ZZZM 323881 Hcl is a potent and selective VEGFR2 inhibitor with IC50 of <2 nM, alm | ||||
| 110604 | Z-VAD-FMK | 187389-52-2 | 98% |  |
| Z-VAD-FMK is a cell-permeable, irreversible broad-spectrum caspase inhibitor, blocks | ||||
| 101201 | 1088965-37-0 | 1088965-37-0 | 98% |  |
| Coming soon! | ||||
| 52555 | ZCL278 | 587841-73-4 | 98% | |
| ZCL278 is a Cdc42 small molecule modulator that directly binds to Cdc42 (Kd=11.4 uM) | ||||
| 52239 | ZM 336372 | 208260-29-1 | 98% |  |
| ZM 336372 is a potent and selective c-Raf inhibitor with IC50 of 70 nM, 10-fold selec | ||||
| 52003 | Zosuquidar trihydrochloride | 167465-36-3 | 99% |  |
| zosuquidar trihydrochloride is adifluorocyclopropyl quinoline. Zosuquidar trihydrochl | ||||